{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:22:54Z","timestamp":1794050574854,"version":"4.8.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.yexcr.2025.114751","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:40:57Z","timestamp":1757781657000},"page":"114751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["N4BP3 promotes ovarian cancer progression and paclitaxel resistance by activating the Wnt\/\u03b2-catenin signaling through interaction with XPO1"],"prefix":"10.1016","volume":"452","author":[{"given":"Mingliang","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2025.114751_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2025.114751_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13048-019-0545-x","article-title":"Effectiveness and safety of the plasmaJet(R) device in advanced stage ovarian carcinoma: a systematic review","volume":"12","author":"Nieuwenhuyzen-de Boer","year":"2019","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.yexcr.2025.114751_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13148-023-01440-w","article-title":"Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review","volume":"15","author":"Terp","year":"2023","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.yexcr.2025.114751_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/AOG.0000000000004173","article-title":"Updates and new options in advanced epithelial ovarian cancer treatment","volume":"137","author":"Kurnit","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.yexcr.2025.114751_bib5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.annonc.2023.07.011","article-title":"Newly diagnosed and relapsed epithelial ovarian cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Gonzalez-Martin","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.yexcr.2025.114751_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/413076","article-title":"Paclitaxel and its evolving role in the management of ovarian cancer","volume":"2015","author":"Kampan","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.yexcr.2025.114751_bib7","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1074\/jbc.M110047200","article-title":"Identification of developmentally expressed proteins that functionally interact with Nedd4 ubiquitin ligase","volume":"277","author":"Murillas","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114751_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1749-8104-8-18","article-title":"The Nedd4-binding protein 3 (N4BP3) is crucial for axonal and dendritic branching in developing neurons","volume":"8","author":"Schmeisser","year":"2013","journal-title":"Neural Dev."},{"key":"10.1016\/j.yexcr.2025.114751_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.770600","article-title":"N4BP3 regulates RIG-I-Like receptor antiviral signaling positively by targeting mitochondrial antiviral signaling protein","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.yexcr.2025.114751_bib10","doi-asserted-by":"crossref","first-page":"45926","DOI":"10.18632\/oncotarget.10002","article-title":"Assessing the clinical utility of genomic expression data across human cancers","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2025.114751_bib11","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/cas.15498","article-title":"N4BP3 promotes angiogenesis in hepatocellular carcinoma by binding with KAT2B","volume":"113","author":"Han","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.yexcr.2025.114751_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2217\/epi-2017-0104","article-title":"The correlation analysis of miRNAs and target genes in metastasis of cervical squamous cell carcinoma","volume":"10","author":"Zhou","year":"2018","journal-title":"Epigenomics"},{"key":"10.1016\/j.yexcr.2025.114751_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215926","article-title":"N4BP3 promotes breast cancer metastasis via NEDD4-mediated E-cadherin ubiquitination and degradation","volume":"550","author":"Luo","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2025.114751_bib14","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s10495-024-01956-3","article-title":"Targeting PNPO to suppress tumor growth via inhibiting autophagic flux and to reverse paclitaxel resistance in ovarian cancer","volume":"29","author":"Li","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.yexcr.2025.114751_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13046-023-02792-0","article-title":"m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN\/PI3K\/AKT pathway","volume":"42","author":"Lin","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114751_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13048-021-00877-y","article-title":"UBE2S promotes the progression and olaparib resistance of ovarian cancer through Wnt\/beta-catenin signaling pathway","volume":"14","author":"Hu","year":"2021","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.yexcr.2025.114751_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.808021","article-title":"Selinexor inhibits growth of patient derived chordomas in vivo as a single agent and in combination with abemaciclib through diverse mechanisms","volume":"12","author":"Walker","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2025.114751_bib18","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.2174\/092986708786242859","article-title":"CRM1-mediated nuclear export of proteins and drug resistance in cancer","volume":"15","author":"Turner","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.yexcr.2025.114751_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3892\/ol.2025.14944","article-title":"Prospects and challenges of ovarian cancer organoids in chemotherapy research","volume":"29","author":"Zhang","year":"2025","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexcr.2025.114751_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-025-02280-3","article-title":"Understanding gold nanoparticles and their attributes in ovarian cancer therapy","volume":"24","author":"Aggarwal","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2025.114751_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17050788","article-title":"Advanced therapeutic approaches for metastatic ovarian cancer","volume":"17","author":"Choe","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.yexcr.2025.114751_bib22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ydbio.2017.01.009","article-title":"The Nedd4 binding protein 3 is required for anterior neural development in Xenopus laevis","volume":"423","author":"Kiem","year":"2017","journal-title":"Dev. Biol."},{"key":"10.1016\/j.yexcr.2025.114751_bib23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12935-024-03415-0","article-title":"Key genes and molecular mechanisms related to paclitaxel resistance","volume":"24","author":"Alalawy","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.yexcr.2025.114751_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15174236","article-title":"Genetics of ABCB1 in cancer","volume":"15","author":"Skinner","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.yexcr.2025.114751_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tjog.2019.10.003","article-title":"Dose-dense chemotherapy with weekly paclitaxel and 3-weekly carboplatin for recurrent ovarian cancer","volume":"59","author":"Chen","year":"2020","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"10.1016\/j.yexcr.2025.114751_bib26","first-page":"1574","article-title":"A single institutional clinical outcome for stages III and IV ovarian cancer patients treated with dose-dense TC therapy in the frontline or first platinum-sensitive relapse setting","volume":"50","author":"Sueoka","year":"2024","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.yexcr.2025.114751_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.yexcr.2025.114751_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41580-024-00823-y","article-title":"Mechanistic insights into wnt-beta-catenin pathway activation and signal transduction","author":"Maurice","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2025.114751_bib29","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1158\/2159-8290.CD-21-0190","article-title":"WNT as a driver and dependency in cancer","volume":"11","author":"Parsons","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.yexcr.2025.114751_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/cpr.12161","article-title":"Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT\/GSK-3beta\/beta-catenin signalling","volume":"48","author":"Zhang","year":"2015","journal-title":"Cell Prolif."},{"key":"10.1016\/j.yexcr.2025.114751_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010450","article-title":"Wnt\/beta-catenin signaling contributes to paclitaxel resistance in bladder cancer cells with cancer stem cell-like properties","volume":"23","author":"Jimenez-Guerrero","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2025.114751_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/sj.cr.7290260","article-title":"Wnt signaling in disease and in development","volume":"15","author":"Nusse","year":"2005","journal-title":"Cell Res."},{"key":"10.1016\/j.yexcr.2025.114751_bib33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12967-025-06362-0","article-title":"TMEM176B inhibits ovarian cancer progression by regulating EMT via the Wnt\/beta-catenin signaling pathway","volume":"23","author":"Yan","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.yexcr.2025.114751_bib34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s12967-022-03635-w","article-title":"Inhibition of XPO1 with KPT-330 induces autophagy-dependent apoptosis in gallbladder cancer by activating the p53\/mTOR pathway","volume":"20","author":"Zhao","year":"2022","journal-title":"J. Transl. Med."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725003519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725003519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T04:15:54Z","timestamp":1758687354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482725003519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0014482725003519"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114751","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N4BP3 promotes ovarian cancer progression and paclitaxel resistance by activating the Wnt\/\u03b2-catenin signaling through interaction with XPO1","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114751"}}